Request a FREE Sample of our FcRn Binding Kit!
Request a FREE Sample of our FcRn Binding Kit!
Limited Edition Golden Llama is here! Check out how you can get one.
Limited Edition Golden Llama is here! Check out how you can get one.
Request a FREE sample of our GMP products!
Request a FREE sample of our GMP products!
Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
LA1-M52H3 | Mouse | Mouse LAIR1 / CD305 Protein, His Tag (MALS verified) | ![]() |
![]() ![]() |
![]() ![]() |
LA1-H82F5 | Human | Biotinylated Human LAIR1 / CD305 Protein, Fc,Avitag™ (MALS verified) | ![]() |
![]() ![]() |
![]() ![]() |
LA1-H5253 | Human | Human LAIR-1 Protein, Mouse IgG2a Fc Tag | ![]() |
![]() ![]() |
![]() ![]() |
LA1-M5254 | Mouse | Mouse LAIR1 / CD305 Protein, Mouse IgG2a Fc Tag, low endotoxin | ![]() |
![]() ![]() |
![]() ![]() |
LA1-C52A3 | Rhesus macaque | Rhesus macaque LAIR-1 / CD305 Protein, Mouse IgG2a Fc Tag | ![]() |
![]() ![]() |
![]() ![]() |
LA1-H82E3 | Human | Biotinylated Human LAIR1 / CD305 Protein, His,Avitag™ | ![]() |
![]() ![]() |
|
LA1-H5252 | Human | Human LAIR1 / CD305 Protein, Fc Tag (MALS verified) | ![]() |
![]() ![]() |
![]() ![]() |
CD5-H52H1 | Human | Human LAIR1 / CD305 Protein, His Tag | ![]() |
![]() ![]() |
Immobilized Native Human Collagen I protein at 10 μg/mL (100 μL/well) can bind Biotinylated Human LAIR-1, Fc,Avitag (Cat. No. LA1-H82F5) with a linear range of 0.01-0.625 μg/mL (QC tested).
The purity of Mouse LAIR1 Protein, His Tag (Cat. No. LA1-M52H3) is more than 90% and the molecular weight of this protein is around 20-28 kDa verified by SEC-MALS.
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
NC-410 | NC-410 | Phase 2 Clinical | Nextcure Inc | Ovarian Neoplasms; Solid tumours; Stomach Neoplasms; Colorectal Neoplasms | Details |
NGM-438 | NGM-438 | Phase 1 Clinical | Merck & Co Inc, Ngm Biopharmaceuticals Inc | Ovarian Neoplasms; Solid tumours; Esophageal Neoplasms; Stomach Neoplasms; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Pancreatic Neoplasms; Carcinoma, Transitional Cell; Mesothelioma; Cholangiocarcinoma; Breast Neoplasms; Prostatic Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms; Melanoma | Details |
NC-410 | NC-410 | Phase 2 Clinical | Nextcure Inc | Ovarian Neoplasms; Solid tumours; Stomach Neoplasms; Colorectal Neoplasms | Details |
NGM-438 | NGM-438 | Phase 1 Clinical | Merck & Co Inc, Ngm Biopharmaceuticals Inc | Ovarian Neoplasms; Solid tumours; Esophageal Neoplasms; Stomach Neoplasms; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Pancreatic Neoplasms; Carcinoma, Transitional Cell; Mesothelioma; Cholangiocarcinoma; Breast Neoplasms; Prostatic Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms; Melanoma | Details |
This web search service is supported by Google Inc.